Sectors

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

Only five months after closing a $541m series A round, SVolt has closed a $1.58bn series B backed by investors including Xiaomi and Sany.

SoftBank’s Vision Fund returned for the $1bn funding round that valued the personal services platform operator at $15bn.

Info Edge, Intel, SoftBank and Tencent are all in line for exits as PolicyBazaar files for an initial public offering in India.

Bolt is valued at more than $4.75bn following a $713m funding round, although its corporate backers did not return for the transaction.

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

SoftBank and PayPal helped the payments platform raise a series B round, which will be used to further boost the expansion of its digital ecosystem.

SoftBank Vision Fund has returned to back the e-learning portal in a round which valued it at $3.44bn and lifted its overall funding to about $860m.